DocDollars

Haemonetics Corporation

MA · United States · Reporting entity ID 100000000340

Total reported 2019–2025
$12.8M
#426 of 2,960 reporting companies — 0% of all reported industry payments
$5.03M in general payments across 8,253 records, plus $7.34M in research funding across 645 records.

How it breaks down

General payments $5,031,392
Research funding $7,335,665
Ownership & investment $412,903

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Haemonetics Corporation reported $12.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #426 of 2,960 reporting companies. 57% of that was research funding and 43% general payments such as consulting, speaking, food and travel. 8,253 general payment records and 645 research records were filed.

Common questions about Haemonetics Corporation

How much has Haemonetics Corporation paid US doctors?

Haemonetics Corporation reported $12,779,959 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,031,392 in general payments, $7,335,665 in research funding and $412,903 in ownership and investment interests.

How does Haemonetics Corporation rank among drug and device companies?

It ranks #426 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Haemonetics Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.